JP2010070573A5 - - Google Patents

Download PDF

Info

Publication number
JP2010070573A5
JP2010070573A5 JP2009295495A JP2009295495A JP2010070573A5 JP 2010070573 A5 JP2010070573 A5 JP 2010070573A5 JP 2009295495 A JP2009295495 A JP 2009295495A JP 2009295495 A JP2009295495 A JP 2009295495A JP 2010070573 A5 JP2010070573 A5 JP 2010070573A5
Authority
JP
Japan
Prior art keywords
changes
neurotransmitters
pain
depression
relationship
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009295495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010070573A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010070573A publication Critical patent/JP2010070573A/ja
Publication of JP2010070573A5 publication Critical patent/JP2010070573A5/ja
Pending legal-status Critical Current

Links

JP2009295495A 2002-04-24 2009-12-25 ストレス関連障害を含む機能的身体障害の予防および処置 Pending JP2010070573A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37506802P 2002-04-24 2002-04-24
US46428803P 2003-04-18 2003-04-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003587377A Division JP2005523334A (ja) 2002-04-24 2003-04-24 ストレス関連障害を含む機能的身体障害の予防および処置

Publications (2)

Publication Number Publication Date
JP2010070573A JP2010070573A (ja) 2010-04-02
JP2010070573A5 true JP2010070573A5 (enExample) 2011-02-10

Family

ID=29273017

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003587377A Withdrawn JP2005523334A (ja) 2002-04-24 2003-04-24 ストレス関連障害を含む機能的身体障害の予防および処置
JP2009295495A Pending JP2010070573A (ja) 2002-04-24 2009-12-25 ストレス関連障害を含む機能的身体障害の予防および処置

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003587377A Withdrawn JP2005523334A (ja) 2002-04-24 2003-04-24 ストレス関連障害を含む機能的身体障害の予防および処置

Country Status (8)

Country Link
US (2) US20030232805A1 (enExample)
EP (1) EP1499309A4 (enExample)
JP (2) JP2005523334A (enExample)
CN (1) CN1662231A (enExample)
AU (1) AU2003225206B2 (enExample)
CA (1) CA2483093A1 (enExample)
MX (1) MXPA04011529A (enExample)
WO (1) WO2003090743A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
TW200402289A (en) * 2002-05-17 2004-02-16 Wyeth Corp Methods of treating gastrointestinary and genitourinary pain disorders
AU2003227519A1 (en) * 2002-05-30 2003-12-19 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
EP1558231A4 (en) * 2002-10-03 2010-09-08 Cypress Bioscience Inc DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS
US7704527B2 (en) * 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
JP2006508978A (ja) * 2002-11-19 2006-03-16 イーライ・リリー・アンド・カンパニー デュロキセチンを用いる胃腸障害の処置
PT1601349E (pt) * 2003-02-14 2008-10-27 Pf Medicament Utilização do enantiómero (1s, 2r) do milnaciprano para a preparação de um medicamento
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
US20070065463A1 (en) * 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
BRPI0413726A (pt) * 2003-09-09 2006-11-07 Pfizer Prod Inc combinação de inibidores da recaptação de serotonina e inibidores da recaptação de norepinefrina
JP2007505095A (ja) * 2003-09-12 2007-03-08 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ
US8309128B2 (en) * 2005-06-10 2012-11-13 Pierre Fabre Medicament Stabilized milnacipran formulation
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
SG183069A1 (en) * 2007-07-23 2012-08-30 Synosia Therapeutics Treatment of post-traumatic stress disorder
US20100040680A1 (en) * 2008-08-15 2010-02-18 Felix Lai Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation
WO2011057176A1 (en) * 2009-11-06 2011-05-12 Forest Laboratories Holding Limited Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
FR2978350B1 (fr) 2011-07-28 2013-11-08 Pf Medicament Medicament a base de levomilnacipran pour la rehabilitation fonctionnelle apres accident neurologique aigu
US11110070B2 (en) 2015-11-17 2021-09-07 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
WO2019094757A1 (en) 2017-11-09 2019-05-16 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders in females
US11622948B2 (en) 2017-11-09 2023-04-11 The Trustees Of Columbia University In The City Of New York Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
US12377112B2 (en) 2019-04-17 2025-08-05 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
EP4076527A4 (en) * 2020-01-10 2024-05-15 Consynance Therapeutics, Inc. Therapeutic combinations of drugs and methods of using them

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
CA2138998A1 (en) * 1992-06-23 1994-01-06 James W. Young Methods and compositions for treating depression and other disorders using optically pure(-) sibutramine
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
WO1995022521A1 (en) * 1994-02-22 1995-08-24 Asahi Kasei Kogyo Kabushiki Kaisha Aminoalkylcyclopropane derivative
ZA958725B (en) * 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
EP0906104A4 (en) * 1996-03-25 2003-12-10 Lilly Co Eli PAIN TREATMENT PROCESS
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
US6284794B1 (en) * 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
CA2289190A1 (en) * 1997-05-07 1998-11-12 Algos Pharmaceutical Corporation Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
ZA989251B (en) * 1997-10-17 2000-04-10 Lilly Co Eli Potentiation of pharmaceuticals.
CA2337507A1 (en) * 1998-07-16 2000-01-27 Massachusetts Institute Of Technology Composition for treatment of stress
SI1113797T1 (sl) * 1998-09-15 2010-02-26 Lilly Co Eli Uporaba duloksetina pri zdravljenju fibromialgije
GB2367748A (en) * 1998-10-27 2002-04-17 Vela Pharmaceuticals Use of optically pure (R)- tofisopam for treating and preventing anxiety disorders and composition thereof
CA2350531A1 (en) * 1998-11-13 2000-05-25 Smriti Iyengar Method for treating pain
US6323242B1 (en) * 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
DE60022692T2 (de) * 1999-07-01 2006-06-22 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
HU229295B1 (en) * 1999-08-04 2013-10-28 Astellas Pharma Inc Stable medicinal compositions for oral use
AR025111A1 (es) * 1999-08-13 2002-11-06 Janus Pharmaceuticals Inc Metodos y composiciones para tratar trastornos de ansiedad generalizada
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
CA2364211A1 (en) * 2000-12-05 2002-06-05 Phillip Branch Chappell Combination treatment for depression, anxiety and psychosis
CA2431041A1 (en) * 2001-01-02 2002-07-11 Pharmacia & Upjohn Company New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
US20020147196A1 (en) * 2001-04-05 2002-10-10 Quessy Steven Noel Composition and method for treating neuropathic pain
BR0208922A (pt) * 2001-04-19 2004-04-20 Warner Lambert Co Aminoácidos bicìclicos ou tricìclicos fundidos
CA2475763A1 (en) * 2002-02-12 2003-08-21 Cypress Bioscience, Inc. Methods of treating attention deficit/hyperactivity disorder (adhd)
AU2003298664A1 (en) 2002-11-20 2004-06-15 Cypress Bioscience, Inc. Treatment of cognitive dysfunctions'

Similar Documents

Publication Publication Date Title
JP2010070573A5 (enExample)
JP2012531046A5 (enExample)
JP2011528458A5 (enExample)
USD623743S1 (en) Orthopedic plate
JP2012512958A5 (enExample)
JP2010518805A5 (enExample)
JP2011526809A5 (enExample)
JP2010535151A5 (enExample)
JP2011100877A5 (enExample)
JP2012247472A5 (enExample)
JP2013513924A5 (enExample)
CL2007000554A1 (es) Metodo para diagnosticar matastasis en el nodulo linfatico de un carcinoma gastrico; y metodo para determinar o ajustar una terapia para un paciente con carcinoma gastrico.
JP2010151225A5 (enExample)
JP2011228592A5 (enExample)
CN300781330S (zh) 客车车身(a)
CN301232455S (zh) 感应垃圾桶（dzt-49-18）
CN301252802S (zh) 感应垃圾桶（dzt-50-20）
CN301245525S (zh) 客车车身
CN300965425S (zh) 电源机柜(1)
CN300809668S (zh) 电源设备
CN301112301S (zh) 柴油机(wp10)
CN300837064S (zh) 摩托车(骏旅)
CN301199831S (zh) 滑模摊铺机
CN301084310S (zh) 圆珠笔
CN301161414S (zh) 悬架